生技新药

学术文章/发表

 


 

ON101

期刊发表 日期 形式 标题

Mary Ann Liebert

2024年9月5日 期刊发表 Effects of ON101 for Hard-to-Heal Diabetic Foot Ulcers in a Randomized Phase III Trial: A Post Hoc Analysis

中华内分泌代谢杂志

2024年7月25日 期刊发表 糖尿病足溃疡创面治疗专家共识(2024)

The Journal of Taiwan Society of Plastic Surgery

2024年6月19日 期刊发表 Efficacy of ON101 cream, a Topical Macrophage-Regulating Cream, against Chronic Burn Wounds—A Case Report and Literature Review

Case Reports in Clinical Medicine

2024年5月28日 期刊发表 ON101 Cream Increases the Wound Healing Rate in Diabetic Patients with Uremia—Cases Report

JAMA Network Open

2023年1月13日 期刊发表 Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective

Aesthetic Surgery Journal

2023年1月10日 期刊发表 Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis 

Annals of Case Reports

2022年12月28日 期刊发表 Macrophage-Regulating Drug Treatment Promotes Tissue Proliferation in a Diabetic Foot Ulcer Patient with Exposed Anterior Tibialis Tendon - A Case Report

Pharmaceutics

2022年9月27日 期刊发表 New Horizons of Macrophage Immunomodulation in the Healing of Diabetic Foot Ulcers

JID Innovations

2022年6月1日 期刊发表 Restoring Pro-healing/remodeling- associated M2a/c Macrophages using ON101 Accelerates Diabetic Wound Healing

JAMA Network Open

2021年9月3日 期刊发表 Effect of a Novel Macrophage-Regulating Drug on Wound Healing in Patients With Diabetic Foot Ulcers

Frontiers in  Pharmacology

2019年5月28日 期刊发表 Extract From Plectranthus amboinicus Inhibit Maturation and Release of Interleukin 1β Through Inhibition of NF-κB Nuclear Translocation and NLRP3 Inflammasome Activation

Evidence-based complementary and alternative medicine

2012年5月30日 期刊发表 Plectranthus Amboinicus and Centella Asiatica Cream for the Treatment of Diabetic Foot Ulcers
会议 日期 形式 标题

TSBIWH Annual Meeting 2024

2024年9月7日 口头报告 人工真皮合并ON101使用于糖尿病足溃疡之案例分享

SAWC Spring 2024

2024年5月14日 海报报告 Optimizing Wound Bed and Diabetic Foot Ulcer Healing with Proprietary Natural Herbal Cream - A Case Series in the US
The Clinical Practice of a Proprietary Natural Herbal Cream in Limb Salvage of a Patient with Multiple Co-morbidities: A Case Report

EADV Congress 2023

2023年10月11日 海报报告 Protection Effect of Macrophage-Regulation Drug for Acute Radiation Dermatitis (ARD):From Preclinical Pharmacology to Real-World Proof-of-Concept Study

EASD Annual Meeting 2023

2023年10月3日 口头报告 Effect of macrophage-regulating new drug in treatment of diabetic foot ulcers- From phase 3 MRCT to real-world

ADA Annual Meeting 2023

2023年6月24日

口头报告 100-OR A novel macrophage-regulation new drug in treating diabetic foot ulcer-a phase III MRCT study and Taiwan experience.

ISPOR 2023

2023年5月10日 海报报告 Economic Value of a Novel Macrophage-Regulating Treatment for Diabetic Foot Ulcers from a Healthcare Sector Perspective
(摘要)


ISDF 2023

2023年5月10日 海报报告 324-Wound Healing Risk Factors - A Phase 3 RCT Post-hoc Analysis of a Novel Macrophage-regulating Drug.
323-The Value of a Novel Macrophage-Regulating Drug for Diabetic Foot Ulcers: A Cost-Effectiveness Analysis
321-Effect of a Macrophage-regulating New Drug in Treatment of Diabetic Foot Ulcers: from Phase 3 RCT to Real-world RCT Post-hoc Analysis of a Novel Macrophage-regulating Drug.

EWMA 2023

2023年5月5日 口头报告 A novel macrophage-regulating drug promotes diabetic foot ulcers healing - Phase 3 MRCT study and post-hoc analysis
A Macrophage-regulating Cream on Wound Healing in Patients with Diabetic Foot Ulcers
(浏览摘要:第441页)

2023 Annual Meeting of TSA

2023年3月18日 海报报告

The effect of topical treatment with Fespixon cream on chronic burn wound: A case report and literature review

2023 Annual Meeting of TSWC

2023年3月11日 口头报告 Effect of a Novel Macrophage-Regulating Drug on complicated Diabetic Foot Ulcers: Case reports
(浏览摘要:第35页)

IDF Diabetes Atlas 2022

2022年12月7日 口头报告 LI2022-0284 Risk Factor Influencing Complete Healing in DFU Patients - Post-Hoc Analysis of a Phase 3 MRCT of Macrophage-Regulation New Drug

CDS 2022

2022年12月4日 口头报告

Macrophage-regulation drug(ON101) In treating difficult Diabetic Foot Ulcer

ESDR
51st Annual Meeting

2022年9月28日 海报报告 Macrophage-regulating Drug Healed a Diabetic foot Ulcer with Gangrene and Osteomyelitis

ADA Annual Meeting 2022

2022年6月1日 海报报告 490-P: Macrophage-Regulating Drug Promotes Tissue Proliferation in a DFU Real-World Case


WUWHS 2022

2022年3月2日 口头报告 A New Drug Promotes Wound Healing in Treatment of Chronic Diabetic Foot Ulcers by Regulating Macrophages
(浏览摘要:第5页)

IDF 2021

2021年12月8日 口头报告 IDF21-0431 A Novel Formulation that Regulates Subsets of Macrophages Accelerates Diabetic Ulcer Healing

EASD Annual Meeting 2021

2021年9月30日 口头报告 A M1/M2-Macrophages-Regulating New Drug for Diabetic Foot Ulcers with Poor-Controlled HbA1c Risk Factor in an International Phase 3 Study
(浏览摘要:196)

EWMA 2020

2020年11月18日 口头报告

A Novel Topic Drug Proved Superior Efficacy from Global Ph3 on Diabetic Foot Ulcer

關閉

建議您使用以下瀏覽器觀看合一網站,
以獲得最佳瀏覽效果。

要下載瀏覽器,請直接點擊以下: IE瀏覽器現已不支援大多數網站,並將於2022年6月終止服務

如何使用IE找到Microsoft Edge?

  1. 開啟新分頁(紅色框)
    開啟新分頁
  2. 於搜尋框中打入Edge(紅色框),並按搜尋(藍色框)
    於搜尋框中打入Edge,並按搜尋
  3. 點擊【立即啟動】(藍框處)打開 Microsoft Edge
    啟動Microsoft Edge